A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
12/2004
12/15/2004	CN1554349A Dry mix formulation for bisphosphonic acids
12/15/2004	CN1179972C Growth hormone secretagogues
12/15/2004	CN1179960C Indole derivatives and their use for treamtent of osteoporosis amongst other applications
12/15/2004	CN1179954C Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg. them
12/15/2004	CN1179952C Pyrimidine-4-one derivatives as LDL-PLA2 inhibitors
12/14/2004	US6831186 Antiinflammatory agents; autoimmune disease
12/14/2004	US6831172 Cross-linked hyaluronic acids and medical uses thereof
12/14/2004	US6831106 Vitamin D analogues
12/14/2004	US6831097 2,3-diaryl-pyrazolo[1,5-B]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (COX-2) inhibitors
12/14/2004	US6831091 Anticancer agents
12/14/2004	US6831085 Methods and compositions utilizing quinazolinones
12/14/2004	US6831075 Heterocyclic substituted pyrazolones
12/14/2004	US6831065 Anti-inflammatory compounds and uses thereof
12/14/2004	CA2284278C Histone containing composition to treat rheumatoid arthritis
12/14/2004	CA2225453C Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis
12/12/2004	CA2465621A1 Pharmaceutical compositions of atorvastatin
12/09/2004	WO2004106384A1 Antibodies to masp-2
12/09/2004	WO2004106381A1 Pharmaceutical compositions comprising bispecific anti-cd3, anti-cd19 antibody constructs for the treatment of b-cell related disorders
12/09/2004	WO2004106321A1 4-aryl-5h-thiophene-2-one derivatives and its preparation and use
12/09/2004	WO2004106312A1 Novel 2-aminoselenazoline derivative and use thereof
12/09/2004	WO2004106285A1 Benzamide nitrile derivatives
12/09/2004	WO2004106280A1 CaSR ANTAGONIST
12/09/2004	WO2004105824A1 A bioabsorbable delivery system
12/09/2004	WO2004105784A1 Class iii slrp agonists for the reduction of blood vessel formation
12/09/2004	WO2004105739A1 Compositions and foods and drinks contiaing higher fatty acid derivative
12/09/2004	WO2004105737A2 Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
12/09/2004	WO2004094388A3 Indazole derivatives as jnk inhibitors
12/09/2004	WO2004080922A3 Substituted vitamin d analogues and their therapeutic uses
12/09/2004	WO2004075863A3 Cxcr3 antagonists
12/09/2004	WO2003105800A3 Film-shaped mucoadhesive administration form for administering cannabis active ingredients
12/09/2004	WO2003097082A3 Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies
12/09/2004	WO2003053219A3 Methods for slowing senescence and treating and preventing diseases associated with senescence
12/09/2004	US20040250306 Transgenic rodent for use as tools in identifying modulator for treatment of diabetes, hypertension, cardiovascular and bone disorders
12/09/2004	US20040249167 Substituted benzopyrans as selective estrogen receptor-beta agonists
12/09/2004	US20040249161 Biphenyl-derivatives as p38-kinase inhibitors
12/09/2004	US20040249158 Amine salts of an integrin receptor antagonist
12/09/2004	US20040249153 For therapy of inflammation, rheumatoid arthritis, osteoarthritis, osteoporosis and tumors
12/09/2004	US20040249132 Nuclear hormone receptor ligand binding domain
12/09/2004	US20040249123 Nuclear receptor for use in identifying modulator for diagnosis, prevention and treatment of cell proliferative, blood, cardiovascular, skin, inflammatory, bone and nervous system disorders
12/09/2004	US20040248954 carbocyclic sulfides such as 3-cyclohexylsulfanyl-5-methoxy-6-methyl-benzo[b]thiophene-2-carboxylic acid (1H-tetrazol-5-yl)-amide, used as phosphatidyl inositol 3-kinase inhibitors; antiinflammatory and anticarcinogenic agents; prophylaxis of cardiovascular disorders
12/09/2004	US20040248949 carbocyclic carboxy nitriles such as 4-chloro-N-[2-({[(1S)-1-cyano-2-thien-3-ylethyl]amino}carbonyl)cyclohexyl]benzamide, used as cathepsin inhibitors; antimetastatic and antitumor agents; prophylaxis of cardiovascular and bone disorders
12/09/2004	US20040248947 N-(3- and 4-substituted phenyl)-2-(arylamino)-benzamides; aralkylation of the 2-primary amine with a benzaldehyde or a pyrid-4-yl carbaldehyde; anticarcinogenic, antitumor agents; enzyme inhibitors of vascular endothelial growth factors
12/09/2004	US20040248936 such as (R)-1-{4-[4-(4-Phenoxy-2-propyl-phenoxy)-butoxy]-benzenesulfonyl}-azetidine-2-carboxylic acid, used as peroxisome proliferator-activated receptor agonists; hypoglycemic agents
12/09/2004	US20040248923 Novel 4-anilinoquinoline-3-carboxamides
12/09/2004	US20040248920 Spiro-hydantoin compounds useful as anti-inflammatory agents
12/09/2004	US20040248897 Substituted N-acylaniline derivatives, the preparation thereof, and their use as pharmaceutical compositions
12/09/2004	US20040248889 Analgesics; synthesis
12/09/2004	US20040248886 Neuronal disorders, autoimmune diseases, cancer, cardiovascular diseases; such as 4-Chloro-N-{5-[1-(4-trifluoromethyl-benzyl)-piperidin-3-ylsulfamoyl]-25 thiophen-2-ylmethyl)-benzamide
12/09/2004	US20040248865 Synergistic mixture containing antiinflammatory agents; rheumatic disorders
12/09/2004	US20040248820 Administering 2-phthalimidoglutaric acid; vision defects; antitumor agents; anticancer agents
12/09/2004	US20040248771 Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect
12/09/2004	US20040248324 Fhm a novel member of the TNF ligand supergene family: materials and methods for interaction modulators
12/09/2004	US20040248188 Methods for using tetanus toxin for benificial purposes in animals (mammals)
12/09/2004	US20040247604 Anti-inflamatory fatty alcohols and fatty acid esters useful as antigen carriers
12/09/2004	US20040247597 Method of treating atherosclerosis and other inflammatory diseases
12/09/2004	CA2527632A1 Benzamide nitrile derivatives
12/09/2004	CA2527429A1 Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
12/09/2004	CA2525695A1 Compositions and foods and drinks containing higher fatty acid derivative
12/09/2004	CA2522586A1 Pharmaceutical compositions comprising bispecific anti-cd3, anti-cd19 antibody constructs for the treatment of b-cell related disorders
12/08/2004	EP1484327A1 Nitrogenous heterocyclic compound and medicine thereof
12/08/2004	EP1484320A1 Jnk inhibitor
12/08/2004	EP1483289A2 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
12/08/2004	EP1483288A2 Hbm variants that modulate bone mass and lipid levels
12/08/2004	EP1483284A2 Selective dipeptide inhibitors of kallikrein
12/08/2004	EP1483263A1 Thiazolyl urea compounds for the treatment of cancer
12/08/2004	EP1483244A1 Cyclic n-substituted alpha iminocarboxylic acids for selectively inhibiting collagenase
12/08/2004	EP1483242A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
12/08/2004	EP1483232A1 Salts of nateglinide
12/08/2004	EP1482984A2 Surrogate antibodies and methods of preparation and use thereof
12/08/2004	EP1482983A2 Non-myeloablative tolerogenic treatment with tyrphostins
12/08/2004	EP1482978A1 Pharmaceutical composition comprising osteoclastogenesis inhibitory factor
12/08/2004	EP1482973A1 Methods of modulating cd200 receptors
12/08/2004	EP1482972A2 Treatment of immunological disorders using anti-cd30 antibodies
12/08/2004	EP1482962A2 Method of treating trx mediated diseases
12/08/2004	EP1482955A1 Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
12/08/2004	EP1482937A2 Novel tyloindicines and related processes, pharmaceutical compositions and methods
12/08/2004	EP1482932A1 N3 alkylated benzimidazole derivatives as mek inhibitors
12/08/2004	EP1482928A2 Mediators of hedgehog signaling pathways,compositions and uses related thereto
12/08/2004	EP1482927A1 Method of treating osteoarthritis
12/08/2004	EP1482926A2 Amino-methyl substituted tetracycline compounds
12/08/2004	EP1482924A2 Cathepsin cysteine protease inhibitors
12/08/2004	EP1482920A1 N-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids
12/08/2004	EP1482896A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
12/08/2004	EP1482895A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
12/08/2004	EP1482872A1 Tissue repair matrix
12/08/2004	EP1482787A2 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
12/08/2004	EP1434886A4 Mid 241 receptor, a novel g-protein coupled receptor
12/08/2004	EP1432312A4 Use of non-toxic crosslinking reagents to improve fatigue resistance and reduce mechanical degradation of intervertebral disc and other collagenous tissues
12/08/2004	EP1363898A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/08/2004	EP1341754B1 Substituted anthranilic acids
12/08/2004	EP1240152B1 Ox(adi)azolyl-hydroxamic acids useful as procollagen c-proteinase inhibitors
12/08/2004	EP1220693B1 Formulations for delivery of osteogenic proteins
12/08/2004	EP1117418B1 Plant extracts for the treatment of increased bone resorption
12/08/2004	EP1027062B1 Germicidal compositions for the treatment of animal infectious diseases of the hoof, comprising a copper salt, a quaternary ammonium compound and a peroxide
12/08/2004	CN2661188Y Acesodyne plaster
12/08/2004	CN2661187Y Plaster administered device for lumbago
12/08/2004	CN1553901A New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds
12/08/2004	CN1553892A Novel compounds and compositions as cathepsin inhibitors
12/08/2004	CN1553806A Use of SAPR-1 for the treatment and/or prevention of scleroderma
12/08/2004	CN1552710A Use of aspergillus fumigatus in antiflammation immunosuppressant

1 ... 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 ... 820